{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:33:58Z","timestamp":1783726438512,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.cllc.2023.04.007","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T12:24:28Z","timestamp":1682511868000},"page":"e198-e204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Characteristics of Patients With Second Primary Lung Cancer Following Breast Cancer: A Retrospective Descriptive Study"],"prefix":"10.1016","volume":"24","author":[{"given":"Kevin Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Shien","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Vempati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Kohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagashree","family":"Seetharamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2023.04.007_bib0001","unstructured":"Cancer of the Breast (Female) - Cancer Stat Facts [Internet]. SEER. [Accessed May 20, 2021]. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/breast.html"},{"issue":"9","key":"10.1016\/j.cllc.2023.04.007_bib0002","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/sj.bjc.6603404","article-title":"Family history of breast cancer and young age at diagnosis of breast cancer increase risk of second primary malignancies in women: a population-based cohort study","volume":"95","author":"Prochazka","year":"2006","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.cllc.2023.04.007_bib0003","first-page":"363","article-title":"Cancer treatment and survivorship statistics, 2019","volume":"69","author":"Miller","year":"2019","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"10.1016\/j.cllc.2023.04.007_bib0004","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1158\/1055-9965.EPI-08-0109","article-title":"Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan","volume":"17","author":"Lee","year":"2008","journal-title":"Cancer Epidemiol Prev Biomark"},{"issue":"1","key":"10.1016\/j.cllc.2023.04.007_bib0005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1634\/theoncologist.12-1-20","article-title":"Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program","volume":"12","author":"Hayat","year":"2007","journal-title":"The Oncologist"},{"issue":"2","key":"10.1016\/j.cllc.2023.04.007_bib0006","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1200\/JGO.2016.003699","article-title":"Second primary cancers after primary breast cancer diagnosis in israeli women, 1992 to 2006","volume":"3","author":"Silverman","year":"2017","journal-title":"J Glob Oncol"},{"issue":"8","key":"10.1016\/j.cllc.2023.04.007_bib0007","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1200\/JCO.2007.11.9081","article-title":"Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study","volume":"26","author":"Schaapveld","year":"2008","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.cllc.2023.04.007_bib0008","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/S0959-8049(02)00089-8","article-title":"Lung cancer risks in women with previous breast cancer","volume":"38","author":"Prochazka","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cllc.2023.04.007_bib0009","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211017757","article-title":"Epidemiology and clinicopathological features of lung cancer in patients with prior history of breast cancer","volume":"9","author":"Wang","year":"2021","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.cllc.2023.04.007_bib0010","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fonc.2018.00427","article-title":"Second primary lung cancer after breast cancer: a population-based study of 6,269 women","volume":"8","author":"Wang","year":"2018","journal-title":"Front Oncol"},{"issue":"39","key":"10.1016\/j.cllc.2023.04.007_bib0011","doi-asserted-by":"crossref","first-page":"e12603","DOI":"10.1097\/MD.0000000000012603","article-title":"Problems to affect long-term survival for breast cancer patients: An observational study of subsequent lung\/bronchus malignancies","volume":"97","author":"Liu","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.cllc.2023.04.007_bib0012","first-page":"1","article-title":"Population-based cohort study reveals distinct associations between female lung cancer and breast cancer in Taiwan","author":"Lin","year":"2018","journal-title":"JCO Clin Cancer Inform"},{"issue":"5","key":"10.1016\/j.cllc.2023.04.007_bib0013","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jtho.2017.01.021","article-title":"Radiation therapy for invasive breast cancer increases the risk of second primary lung cancer: a Nationwide population-based cohort analysis","volume":"12","author":"Huang","year":"2017","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.cllc.2023.04.007_bib0014","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/bjc.2016.108","article-title":"A population-based analysis of secondary malignancies in breast cancer patients receiving breast reconstruction","volume":"115","author":"Warschkow","year":"2016","journal-title":"Br J Cancer"},{"issue":"10","key":"10.1016\/j.cllc.2023.04.007_bib0015","first-page":"1721","article-title":"The risk of a second primary lung cancer after a first invasive breast cancer according to estrogen receptor status","volume":"23","author":"Schonfeld","year":"2012","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.cllc.2023.04.007_bib0016","first-page":"1121","article-title":"Second primary lung cancers among breast cancer patients treated with anti-estrogens have a longer cancer-specific survival","volume":"7","author":"Hsu","year":"2015","journal-title":"ANTICANCER Res"},{"key":"10.1016\/j.cllc.2023.04.007_bib0017","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canep.2017.02.010","article-title":"Antiestrogen use in breast cancer patients reduces the risk of subsequent lung cancer: a population-based study","volume":"48","author":"Chu","year":"2017","journal-title":"Cancer Epidemiol"},{"issue":"8","key":"10.1016\/j.cllc.2023.04.007_bib0018","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/JTO.0000000000000213","article-title":"Non\u2013small-cell lung cancer after breast cancer: a population-based study of clinicopathologic characteristics and survival outcomes in 3529 women","volume":"9","author":"Milano","year":"2014","journal-title":"J Thorac Oncol"},{"issue":"8","key":"10.1016\/j.cllc.2023.04.007_bib0019","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/annonc\/mdw209","article-title":"Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic","volume":"27","author":"Winter","year":"2016","journal-title":"Ann Oncol"},{"issue":"15","key":"10.1016\/j.cllc.2023.04.007_bib0020","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1200\/JCO.18.01854","article-title":"Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients","volume":"37","author":"Kurian","year":"2019","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.cllc.2023.04.007_bib0021","doi-asserted-by":"crossref","DOI":"10.1177\/1559325818796331","article-title":"Health impacts of low-dose ionizing radiation: current scientific debates and regulatory issues","volume":"16","author":"Vaiserman","year":"2018","journal-title":"Dose-Response"},{"issue":"1","key":"10.1016\/j.cllc.2023.04.007_bib0022","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2217\/lmt.13.67","article-title":"Targeting the estrogen pathway for the treatment and prevention of lung cancer","volume":"3","author":"Burns","year":"2014","journal-title":"Lung Cancer Manag"},{"key":"10.1016\/j.cllc.2023.04.007_bib0023","doi-asserted-by":"crossref","unstructured":"Aromatase Inhibitors in Human Lung Cancer Therapy | Cancer Research [Internet]. [Accessed May 21, 2021]. Available from: https:\/\/cancerres.aacrjournals.org\/content\/65\/24\/11287.long","DOI":"10.1158\/0008-5472.CAN-05-2737"},{"issue":"11","key":"10.1016\/j.cllc.2023.04.007_bib0024","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/carcin\/bgs260","article-title":"Prevention of tobacco carcinogen-induced lung cancer in female mice using antiestrogens","volume":"33","author":"Stabile","year":"2012","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.cllc.2023.04.007_bib0025","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"1","key":"10.1016\/j.cllc.2023.04.007_bib0026","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.radonc.2013.01.002","article-title":"Second primary cancers after adjuvant radiotherapy in early breast cancer patients: a national population based study under the Danish Breast Cancer Cooperative Group (DBCG)","volume":"106","author":"Grantzau","year":"2013","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.cllc.2023.04.007_bib0027","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.radonc.2014.05.004","article-title":"Risk of second primary lung cancer in women after radiotherapy for breast cancer","volume":"111","author":"Grantzau","year":"2014","journal-title":"Radiother Oncol"},{"issue":"12","key":"10.1016\/j.cllc.2023.04.007_bib0028","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S1470-2045(10)70056-5","article-title":"Lung cancer after treatment for breast cancer","volume":"11","author":"Lorigan","year":"2010","journal-title":"Lancet Oncol"},{"issue":"15","key":"10.1016\/j.cllc.2023.04.007_bib0029","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1200\/JCO.2016.72.0722","article-title":"Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials","volume":"35","author":"Taylor","year":"2017","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.cllc.2023.04.007_bib0030","first-page":"200","article-title":"Smoking and lung cancer","volume":"53","author":"Ozl\u00fc","year":"2005","journal-title":"Tuberk Ve Toraks"},{"issue":"10","key":"10.1016\/j.cllc.2023.04.007_bib0031","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.3390\/cancers12102943","article-title":"No impact of smoking status on breast cancer tumor infiltrating lymphocytes, response to neoadjuvant chemotherapy and prognosis","volume":"12","author":"Simon","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.cllc.2023.04.007_bib0032","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1186\/s12885-017-3611-z","article-title":"The association between smoking and breast cancer characteristics and outcome","volume":"17","author":"Goldvaser","year":"2017","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.cllc.2023.04.007_bib0033","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/0284186X.2016.1273547","article-title":"Long-term effects on the incidence of second primary cancers in a randomized trial of two and five years of adjuvant tamoxifen","volume":"56","author":"Rosell","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.cllc.2023.04.007_bib0034","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.annonc.2020.03.022","article-title":"82P A multinational study of real-world treatment patterns among patients with early stage HR+\/HER2- breast cancer (BC)","volume":"31","author":"Criscitiello","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2023.04.007_bib0035","doi-asserted-by":"crossref","unstructured":"Hu X, Yang D, Li Y, et\u00a0al. Prevalence and clinical significance of pathogenic germline BRCA1\/2 mutations in Chinese non-small cell lung cancer patients. 2019;16(3):10.","DOI":"10.20892\/j.issn.2095-3941.2018.0506"},{"issue":"7","key":"10.1016\/j.cllc.2023.04.007_bib0036","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/ng.3002","article-title":"Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer","volume":"46","author":"Wang","year":"2014","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.cllc.2023.04.007_bib0037","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/oxfordjournals.annonc.a059008","article-title":"Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer","volume":"5","author":"Valagussa","year":"1994","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.cllc.2023.04.007_bib0038","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1097\/MLR.0000000000000073","article-title":"Comparison of SEER treatment data with Medicare claims","volume":"54","author":"Noone","year":"2016","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.cllc.2023.04.007_bib0039","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00432-019-03084-x","article-title":"Marital status independently predicts non-small cell lung cancer survival: a propensity-adjusted SEER database analysis","volume":"146","author":"Chen","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"10.1016\/j.cllc.2023.04.007_bib0040","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000495666","article-title":"A single-center retrospective study of patients with double primary cancers: breast cancer and EGFR-mutant non-small cell lung cancer","volume":"42","author":"Moran","year":"2019","journal-title":"Oncol Res Treat"},{"issue":"48","key":"10.1016\/j.cllc.2023.04.007_bib0041","doi-asserted-by":"crossref","first-page":"78985","DOI":"10.18632\/oncotarget.12587","article-title":"The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cllc.2023.04.007_bib0042","unstructured":"Who Should Be Screened for Lung Cancer? | CDC [Internet]. 2022 [Accessed April 8, 2023]. Available from: https:\/\/www.cdc.gov\/cancer\/lung\/basic_info\/screening.htm"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730423000748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730423000748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:15:08Z","timestamp":1761506108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730423000748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1525730423000748"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2023.04.007","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of Patients With Second Primary Lung Cancer Following Breast Cancer: A Retrospective Descriptive Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2023.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}